| Year |
Citation |
Score |
| 2020 |
Yoshida T, Delafontaine P. Mechanisms of IGF-1-Mediated Regulation of Skeletal Muscle Hypertrophy and Atrophy. Cells. 9. PMID 32858949 DOI: 10.3390/Cells9091970 |
0.537 |
|
| 2020 |
Hou X, Li Z, Higashi Y, Delafontaine P, Sukhanov S. Insulin-Like Growth Factor I Prevents Cellular Aging via Activation of Mitophagy. Journal of Aging Research. 2020: 4939310. PMID 32802505 DOI: 10.1155/2020/4939310 |
0.38 |
|
| 2020 |
Higashi Y, Sukhanov S, Shai SY, Danchuk S, Snarski P, Li Z, Hou X, Hamblin MH, Woods TC, Wang M, Wang D, Yu H, Korthuis RJ, Yoshida T, Delafontaine P. Endothelial Deficiency of Insulin-like Growth Factor -1 Receptor Reduces Endothelial Barrier Function and Promotes Atherosclerosis in Apoe-Deficient Mice. American Journal of Physiology. Heart and Circulatory Physiology. PMID 32795184 DOI: 10.1152/Ajpheart.00064.2020 |
0.367 |
|
| 2020 |
Chaanine AH, Navar LG, Delafontaine P. A Rat Model of Pressure Overload Induced Moderate Remodeling and Systolic Dysfunction as Opposed to Overt Systolic Heart Failure. Journal of Visualized Experiments : Jove. PMID 32420983 DOI: 10.3791/60954 |
0.312 |
|
| 2019 |
Silva KAS, Ghiarone T, Schreiber K, Grant D, White T, Frisard MI, Sukhanov S, Chandrasekar B, Delafontaine P, Yoshida T. Angiotensin II suppresses autophagy and disrupts the ultrastructural morphology and function of mitochondria in mouse skeletal muscle. Journal of Applied Physiology (Bethesda, Md. : 1985). PMID 30946636 DOI: 10.1152/Japplphysiol.00898.2018 |
0.557 |
|
| 2018 |
Sukhanov S, Higashi Y, Shai SY, Snarski P, Danchuk S, D'Ambra V, Tabony M, Woods TC, Hou X, Li Z, Ozoe A, Chandrasekar B, Takahashi SI, Delafontaine P. SM22α (Smooth Muscle Protein 22-α) Promoter-Driven IGF1R (Insulin-Like Growth Factor 1 Receptor) Deficiency Promotes Atherosclerosis. Arteriosclerosis, Thrombosis, and Vascular Biology. 38: 2306-2317. PMID 30354209 DOI: 10.1161/ATVBAHA.118.311134 |
0.37 |
|
| 2017 |
Kim SC, Boese AC, Moore MH, Cleland RM, Chang L, Delafontaine P, Yin KJ, Lee JP, Hamblin MH. Rapid estrogen receptor alpha signaling mediated by ERK activation regulates vascular tone in male and ovary-intact female mice. American Journal of Physiology. Heart and Circulatory Physiology. ajpheart.00841.2016. PMID 28887333 DOI: 10.1152/Ajpheart.00841.2016 |
0.321 |
|
| 2016 |
Delafontaine P, Yoshida T. THE RENIN-ANGIOTENSIN SYSTEM AND THE BIOLOGY OF SKELETAL MUSCLE: MECHANISMS OF MUSCLE WASTING IN CHRONIC DISEASE STATES. Transactions of the American Clinical and Climatological Association. 127: 245-258. PMID 28066057 |
0.547 |
|
| 2016 |
Yoshida T, Delafontaine P. An Intronic Enhancer Element Regulates Angiotensin II Type 2 Receptor Expression During Satellite Cell Differentiation and Its Activity Is Suppressed In Congestive Heart Failure. The Journal of Biological Chemistry. PMID 27756842 DOI: 10.1074/jbc.M116.752501 |
0.493 |
|
| 2016 |
Sakamuri SS, Valente AJ, Siddesha JM, Delafontaine P, Siebenlist U, Gardner JD, Chandrasekar B. TRAF3IP2 Mediates Aldosterone/Salt-Induced Cardiac Hypertrophy and Fibrosis. Molecular and Cellular Endocrinology. PMID 27040306 DOI: 10.1016/J.Mce.2016.03.038 |
0.377 |
|
| 2016 |
Somanna NK, Valente AJ, Krenz M, Fay WP, Delafontaine P, Chandrasekar B. The Nox1/4 Dual Inhibitor GKT137831 or Nox4 Knockdown Inhibits Angiotensin-II-Induced Adult Mouse Cardiac Fibroblast Proliferation and Migration. AT1 Physically Associates With Nox4. Journal of Cellular Physiology. 231: 1130-41. PMID 26445208 DOI: 10.1002/jcp.25210 |
0.352 |
|
| 2015 |
Yoshida T, Delafontaine P. Mechanisms of Cachexia in Chronic Disease States. The American Journal of the Medical Sciences. 350: 250-6. PMID 26083652 DOI: 10.1097/MAJ.0000000000000511 |
0.566 |
|
| 2015 |
Sukhanov S, Snarski P, Vaughn C, Lobelle-Rich P, Kim C, Higashi Y, Shai SY, Delafontaine P. Insulin-like growth factor I reduces lipid oxidation and foam cell formation via downregulation of 12/15-lipoxygenase. Atherosclerosis. 238: 313-20. PMID 25549319 DOI: 10.1016/J.Atherosclerosis.2014.12.024 |
0.324 |
|
| 2014 |
Tabony AM, Yoshida T, Sukhanov S, Delafontaine P. Protein phosphatase 2C-alpha knockdown reduces angiotensin II-mediated skeletal muscle wasting via restoration of mitochondrial recycling and function. Skeletal Muscle. 4: 20. PMID 25625009 DOI: 10.1186/2044-5040-4-20 |
0.776 |
|
| 2014 |
Yoshida T, Huq TS, Delafontaine P. Angiotensin type 2 receptor signaling in satellite cells potentiates skeletal muscle regeneration. The Journal of Biological Chemistry. 289: 26239-48. PMID 25112871 DOI: 10.1074/jbc.M114.585521 |
0.523 |
|
| 2014 |
Higashi Y, Quevedo HC, Tiwari S, Sukhanov S, Shai SY, Anwar A, Delafontaine P. Interaction between insulin-like growth factor-1 and atherosclerosis and vascular aging. Frontiers of Hormone Research. 43: 107-24. PMID 24943302 DOI: 10.1159/000360571 |
0.344 |
|
| 2014 |
Blackstock CD, Higashi Y, Sukhanov S, Shai SY, Stefanovic B, Tabony AM, Yoshida T, Delafontaine P. Insulin-like growth factor-1 increases synthesis of collagen type I via induction of the mRNA-binding protein LARP6 expression and binding to the 5' stem-loop of COL1a1 and COL1a2 mRNA. The Journal of Biological Chemistry. 289: 7264-74. PMID 24469459 DOI: 10.1074/Jbc.M113.518951 |
0.742 |
|
| 2014 |
Siddesha JM, Valente AJ, Yoshida T, Sakamuri SS, Delafontaine P, Iba H, Noda M, Chandrasekar B. Docosahexaenoic acid reverses angiotensin II-induced RECK suppression and cardiac fibroblast migration. Cellular Signalling. 26: 933-41. PMID 24447911 DOI: 10.1016/J.Cellsig.2014.01.005 |
0.425 |
|
| 2013 |
Yoshida T, Galvez S, Tiwari S, Rezk BM, Semprun-Prieto L, Higashi Y, Sukhanov S, Yablonka-Reuveni Z, Delafontaine P. Angiotensin II inhibits satellite cell proliferation and prevents skeletal muscle regeneration. The Journal of Biological Chemistry. 288: 23823-32. PMID 23831688 DOI: 10.1074/Jbc.M112.449074 |
0.835 |
|
| 2013 |
Yoshida T, Tabony AM, Galvez S, Mitch WE, Higashi Y, Sukhanov S, Delafontaine P. Molecular mechanisms and signaling pathways of angiotensin II-induced muscle wasting: potential therapeutic targets for cardiac cachexia. The International Journal of Biochemistry & Cell Biology. 45: 2322-32. PMID 23769949 DOI: 10.1016/j.biocel.2013.05.035 |
0.801 |
|
| 2013 |
Song YH, Song JL, Delafontaine P, Godard MP. The therapeutic potential of IGF-I in skeletal muscle repair. Trends in Endocrinology and Metabolism: Tem. 24: 310-9. PMID 23628587 DOI: 10.1016/J.Tem.2013.03.004 |
0.483 |
|
| 2013 |
Valente AJ, Yoshida T, Izadpanah R, Delafontaine P, Siebenlist U, Chandrasekar B. Interleukin-18 enhances IL-18R/Nox1 binding, and mediates TRAF3IP2-dependent smooth muscle cell migration. Inhibition by simvastatin. Cellular Signalling. 25: 1447-56. PMID 23541442 DOI: 10.1016/J.Cellsig.2013.03.007 |
0.304 |
|
| 2013 |
Valente AJ, Yoshida T, Clark RA, Delafontaine P, Siebenlist U, Chandrasekar B. Advanced oxidation protein products induce cardiomyocyte death via Nox2/Rac1/superoxide-dependent TRAF3IP2/JNK signaling. Free Radical Biology & Medicine. 60: 125-35. PMID 23453926 DOI: 10.1016/J.Freeradbiomed.2013.02.012 |
0.34 |
|
| 2013 |
Higashi Y, Pandey A, Goodwin B, Delafontaine P. Insulin-like growth factor-1 regulates glutathione peroxidase expression and activity in vascular endothelial cells: Implications for atheroprotective actions of insulin-like growth factor-1. Biochimica Et Biophysica Acta. 1832: 391-9. PMID 23261989 DOI: 10.1016/J.Bbadis.2012.12.005 |
0.397 |
|
| 2012 |
Godard MP, Whitman SA, Song YH, Delafontaine P. Skeletal muscle molecular alterations precede whole-muscle dysfunction in NYHA Class II heart failure patients. Clinical Interventions in Aging. 7: 489-97. PMID 23204842 DOI: 10.2147/Cia.S37879 |
0.52 |
|
| 2012 |
Valente AJ, Yoshida T, Murthy SN, Sakamuri SS, Katsuyama M, Clark RA, Delafontaine P, Chandrasekar B. Angiotensin II enhances AT1-Nox1 binding and stimulates arterial smooth muscle cell migration and proliferation through AT1, Nox1, and interleukin-18. American Journal of Physiology. Heart and Circulatory Physiology. 303: H282-96. PMID 22636674 DOI: 10.1152/Ajpheart.00231.2012 |
0.465 |
|
| 2012 |
Higashi Y, Sukhanov S, Anwar A, Shai SY, Delafontaine P. Aging, atherosclerosis, and IGF-1. The Journals of Gerontology. Series a, Biological Sciences and Medical Sciences. 67: 626-39. PMID 22491965 DOI: 10.1093/Gerona/Gls102 |
0.362 |
|
| 2012 |
Rezk BM, Yoshida T, Semprun-Prieto L, Higashi Y, Sukhanov S, Delafontaine P. Angiotensin II infusion induces marked diaphragmatic skeletal muscle atrophy. Plos One. 7: e30276. PMID 22276172 DOI: 10.1371/Journal.Pone.0030276 |
0.83 |
|
| 2012 |
Yoshida T, Semprun-Prieto L, Wainford RD, Sukhanov S, Kapusta DR, Delafontaine P. Angiotensin II reduces food intake by altering orexigenic neuropeptide expression in the mouse hypothalamus. Endocrinology. 153: 1411-20. PMID 22234465 DOI: 10.1210/En.2011-1764 |
0.807 |
|
| 2011 |
Tabony AM, Yoshida T, Galvez S, Higashi Y, Sukhanov S, Chandrasekar B, Mitch WE, Delafontaine P. Angiotensin II upregulates protein phosphatase 2Cα and inhibits AMP-activated protein kinase signaling and energy balance leading to skeletal muscle wasting. Hypertension. 58: 643-9. PMID 21844485 DOI: 10.1161/Hypertensionaha.111.174839 |
0.797 |
|
| 2011 |
Sukhanov S, Semprun-Prieto L, Yoshida T, Michael Tabony A, Higashi Y, Galvez S, Delafontaine P. Angiotensin II, oxidative stress and skeletal muscle wasting. The American Journal of the Medical Sciences. 342: 143-7. PMID 21747283 DOI: 10.1097/Maj.0B013E318222E620 |
0.825 |
|
| 2011 |
Semprun-Prieto LC, Sukhanov S, Yoshida T, Rezk BM, Gonzalez-Villalobos RA, Vaughn C, Michael Tabony A, Delafontaine P. Angiotensin II induced catabolic effect and muscle atrophy are redox dependent. Biochemical and Biophysical Research Communications. 409: 217-21. PMID 21570954 DOI: 10.1016/J.Bbrc.2011.04.122 |
0.831 |
|
| 2011 |
Shanmugam P, Valente AJ, Prabhu SD, Venkatesan B, Yoshida T, Delafontaine P, Chandrasekar B. Angiotensin-II type 1 receptor and NOX2 mediate TCF/LEF and CREB dependent WISP1 induction and cardiomyocyte hypertrophy. Journal of Molecular and Cellular Cardiology. 50: 928-38. PMID 21376054 DOI: 10.1016/J.Yjmcc.2011.02.012 |
0.525 |
|
| 2011 |
Shai SY, Sukhanov S, Higashi Y, Vaughn C, Rosen CJ, Delafontaine P. Low circulating insulin-like growth factor I increases atherosclerosis in ApoE-deficient mice. American Journal of Physiology. Heart and Circulatory Physiology. 300: H1898-906. PMID 21335474 DOI: 10.1152/Ajpheart.01081.2010 |
0.364 |
|
| 2011 |
Reddy VS, Valente AJ, Delafontaine P, Chandrasekar B. Interleukin-18/WNT1-inducible signaling pathway protein-1 signaling mediates human saphenous vein smooth muscle cell proliferation. Journal of Cellular Physiology. 226: 3303-15. PMID 21321938 DOI: 10.1002/Jcp.22676 |
0.343 |
|
| 2010 |
Higashi Y, Holder K, Delafontaine P. Thiazolidinediones up-regulate insulin-like growth factor-1 receptor via a peroxisome proliferator-activated receptor gamma-independent pathway. The Journal of Biological Chemistry. 285: 36361-8. PMID 20843793 DOI: 10.1074/Jbc.M110.137661 |
0.369 |
|
| 2010 |
Shai SY, Sukhanov S, Higashi Y, Vaughn C, Kelly J, Delafontaine P. Smooth muscle cell-specific insulin-like growth factor-1 overexpression in Apoe-/- mice does not alter atherosclerotic plaque burden but increases features of plaque stability. Arteriosclerosis, Thrombosis, and Vascular Biology. 30: 1916-24. PMID 20671230 DOI: 10.1161/Atvbaha.110.210831 |
0.42 |
|
| 2010 |
Venkatesan B, Valente AJ, Prabhu SD, Shanmugam P, Delafontaine P, Chandrasekar B. EMMPRIN activates multiple transcription factors in cardiomyocytes, and induces interleukin-18 expression via Rac1-dependent PI3K/Akt/IKK/NF-kappaB andMKK7/JNK/AP-1 signaling. Journal of Molecular and Cellular Cardiology. 49: 655-63. PMID 20538003 DOI: 10.1016/J.Yjmcc.2010.05.007 |
0.318 |
|
| 2010 |
Yoshida T, Semprun-Prieto L, Sukhanov S, Delafontaine P. IGF-1 prevents ANG II-induced skeletal muscle atrophy via Akt- and Foxo-dependent inhibition of the ubiquitin ligase atrogin-1 expression. American Journal of Physiology. Heart and Circulatory Physiology. 298: H1565-70. PMID 20228261 DOI: 10.1152/Ajpheart.00146.2010 |
0.837 |
|
| 2010 |
Venkatesan B, Prabhu SD, Venkatachalam K, Mummidi S, Valente AJ, Clark RA, Delafontaine P, Chandrasekar B. WNT1-inducible signaling pathway protein-1 activates diverse cell survival pathways and blocks doxorubicin-induced cardiomyocyte death. Cellular Signalling. 22: 809-20. PMID 20074638 DOI: 10.1016/J.Cellsig.2010.01.005 |
0.361 |
|
| 2010 |
Higashi Y, Sukhanov S, Anwar A, Shai SY, Delafontaine P. IGF-1, oxidative stress and atheroprotection. Trends in Endocrinology and Metabolism: Tem. 21: 245-54. PMID 20071192 DOI: 10.1016/J.Tem.2009.12.005 |
0.359 |
|
| 2009 |
Titterington JS, Sukhanov S, Higashi Y, Vaughn C, Bowers C, Delafontaine P. Growth hormone-releasing peptide-2 suppresses vascular oxidative stress in ApoE-/- mice but does not reduce atherosclerosis. Endocrinology. 150: 5478-87. PMID 19819949 DOI: 10.1210/En.2009-0283 |
0.395 |
|
| 2009 |
Lee RH, Pulin AA, Seo MJ, Kota DJ, Ylostalo J, Larson BL, Semprun-Prieto L, Delafontaine P, Prockop DJ. Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6. Cell Stem Cell. 5: 54-63. PMID 19570514 DOI: 10.1016/J.Stem.2009.05.003 |
0.737 |
|
| 2009 |
Zhang L, Du J, Hu Z, Han G, Delafontaine P, Garcia G, Mitch WE. IL-6 and serum amyloid A synergy mediates angiotensin II-induced muscle wasting. Journal of the American Society of Nephrology : Jasn. 20: 604-12. PMID 19158350 DOI: 10.1681/Asn.2008060628 |
0.487 |
|
| 2008 |
Higashi Y, Sukhanov S, Parthasarathy S, Delafontaine P. The ubiquitin ligase Nedd4 mediates oxidized low-density lipoprotein-induced downregulation of insulin-like growth factor-1 receptor. American Journal of Physiology. Heart and Circulatory Physiology. 295: H1684-9. PMID 18723765 DOI: 10.1152/Ajpheart.00548.2008 |
0.357 |
|
| 2007 |
Santini MP, Tsao L, Monassier L, Theodoropoulos C, Carter J, Lara-Pezzi E, Slonimsky E, Salimova E, Delafontaine P, Song YH, Bergmann M, Freund C, Suzuki K, Rosenthal N. Enhancing repair of the mammalian heart. Circulation Research. 100: 1732-40. PMID 17525368 DOI: 10.1161/Circresaha.107.148791 |
0.349 |
|
| 2007 |
Godard MP, Whitman SA, Song Y, Delafontaine P. Skeletal Single Muscle Fiber Myosin Heavy Chain Composition and IGF-1 mRNA Expression with Heart Failure Medicine & Science in Sports & Exercise. 39: S36-S37. DOI: 10.1249/01.Mss.0000273028.05333.B3 |
0.418 |
|
| 2006 |
Delafontaine P, Akao M. Angiotensin II as candidate of cardiac cachexia. Current Opinion in Clinical Nutrition and Metabolic Care. 9: 220-4. PMID 16607120 DOI: 10.1097/01.Mco.0000222103.29009.70 |
0.446 |
|
| 2006 |
Ma Y, Zhang L, Peng T, Cheng J, Taneja S, Zhang J, Delafontaine P, Du J. Angiotensin II stimulates transcription of insulin-like growth factor I receptor in vascular smooth muscle cells: role of nuclear factor-kappaB. Endocrinology. 147: 1256-63. PMID 16322063 DOI: 10.1210/En.2005-0888 |
0.527 |
|
| 2003 |
Li Y, Higashi Y, Itabe H, Song YH, Du J, Delafontaine P. Insulin-like growth factor-1 receptor activation inhibits oxidized LDL-induced cytochrome C release and apoptosis via the phosphatidylinositol 3 kinase/Akt signaling pathway. Arteriosclerosis, Thrombosis, and Vascular Biology. 23: 2178-84. PMID 14551153 DOI: 10.1161/01.Atv.0000099788.31333.Db |
0.438 |
|
| Show low-probability matches. |